Objective: To determine the test performance of leukocytosis for ident
ifying acute myocardial infarction (AMI) in patients with nondiagnosti
c ECGs, admitted to rule out AMI. Methods: A retrospective, comparativ
e test performance study was conducted using patients admitted to a un
iversity teaching hospital to rule out AMI, Clinical and laboratory in
formation was reviewed and hospital laboratory ranges were used to def
ine threshold elevations: total creatine kinase (CK), 275 U/L; CK-MB,
7.5 mu g/L; white blood cell (WBC) count, 11.5 x 10(9)/L; and absolute
neutrophil count (ANC), 8.0 x 10(9). Sensitivity, specificity, and pr
edictive values of the total CK, CK-MB, WBC count, and ANC were calcul
ated, and receiver operating characteristic (ROC) curves constructed.
Test performances of marker combinations also were determined. Results
: The initial WBC count was significantly higher for the subjects who
had AMI (11.1 vs 8.8 x 10(9)/L, p < 0.001), For the 688 subjects who h
ad nondiagnostic ECGs, sensitivities for the initial total CK, CK-MB,
WBC, and ANC were 39%, 73%, 35%, and 36%, respectively, while the corr
esponding specificities were 94%, 93%, 85%, acid 86%. Logistic regress
ion analysis confirmed leukocytosis as an independent predictor of AMI
(adjusted odds ratio 4.08, 95% CI 1.73-9.63), While CK-MB alone was 7
3% sensitive for AMI, the decision rule of either an elevated CK-MB or
an elevated WBC count increased this sensitivity to 88% (correspondin
g specificity 79%). Similarly, while CK-MB alone was 93% specific for
AMI, the combination of an elevated CK-MB and an elevated WBC count in
creased this specificity to 99% (corresponding sensitivity 20%). Concl
usions: Leukocytosis is significantly associated with AMI, and is a we
ak but independent laboratory predictor of this condition, In this pre
liminary study of admitted patients suspected of AMI, the combination
of the WBC and the CK-MB may have additional diagnostic value over an
isolated CK-MB result. Neither parameter in isolation was satisfactori
ly sensitive for AMI. Prognostic assessment of the role of the WBC cou
nt in clinical decision making should address its complementary role t
o that of other clinical and ancillary test parameters.